Loring Wolcott & Coolidge Fiduciary Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2K | Hold |
190
| – | – | ﹤0.01% | 451 |
|
|
2025
Q1 | $21.8K | Hold |
190
| – | – | ﹤0.01% | 439 |
|
|
2024
Q4 | $22.8K | Hold |
190
| – | – | ﹤0.01% | 446 |
|
|
2024
Q3 | $21.2K | Hold |
190
| – | – | ﹤0.01% | 454 |
|
|
2024
Q2 | $16.5K | Hold |
190
| – | – | ﹤0.01% | 465 |
|
|
2024
Q1 | $16.7K | Hold |
190
| – | – | ﹤0.01% | 470 |
|
|
2023
Q4 | $18.1K | Hold |
190
| – | – | ﹤0.01% | 466 |
|
|
2023
Q3 | $17.6K | Buy |
+190
| New | +$17.6K | ﹤0.01% | 493 |
|
|
2023
Q2 | – | Sell |
-250
| Closed | -$31.1K | – | 635 |
|
|
2023
Q1 | $31.1K | Hold |
250
| – | – | ﹤0.01% | 446 |
|
|
2022
Q4 | $37.6K | Hold |
250
| – | – | ﹤0.01% | 434 |
|
|
2022
Q3 | $34K | Hold |
250
| – | – | ﹤0.01% | 459 |
|
|
2022
Q2 | $37K | Hold |
250
| – | – | ﹤0.01% | 460 |
|
|
2022
Q1 | $43K | Buy |
250
+100
| +67% | +$17.2K | ﹤0.01% | 457 |
|
|
2021
Q4 | $39K | Buy |
150
+50
| +50% | +$13K | ﹤0.01% | 483 |
|
|
2021
Q3 | $27K | Buy |
+100
| New | +$27K | ﹤0.01% | 505 |
|